Osteoarthritis (OA), the most common of all arthritic conditions, is characterized by joint pain and stiffness. It is a common and significant chronic musculoskeletal disease that reduces mobility and has a considerable impact on quality of life. Over 50% of people over the age of 65 years have radiological evidence of the disease, and approximately 10%..
About Brainrootz Labs
BRAINROOTZ LABS is a Indian company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, transforms scientific innovation into healthcare solutions, in Oncology, Urology, Critical Care, Antibacterial, Cardiovascular, and Nutritionals diseases. So many people at Brainrootz Labs are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.
SPECIALTIES
Cancer of the bladder, the organ that stores and releases urine while voiding, is more common in men than women, by at least 3- 4 times. Like most other tumours of the urinary tract, the incidence of bladder cancer is also rare, under the age of 40 years. That said, like all other cancers, of late bladder cancers affects younger people too without any of the known risk factors.
For a long time, peritoneal cancer was thought to be a very rare disease. This perception may still be true for specific subtypes of peritoneal cancer, such as malignant mesothelioma and pseudomyxoma peritonei (PMP). However, every year hundreds of thousands of patients around the world are diagnosed with peritoneal cancer originating from a primary tumor located elsewhere in the body, such as colon cancer, gastric cancer or ovarian cancer.
Monoclonal antibodies, also known as therapeutic antibodies, are proteins produced in the lab. These proteins are designed to attach to specific targets found on cancer cells. Some monoclonal antibodies mark cancer cells so that they will be better seen and destroyed by the immune system. Other monoclonal antibodies directly stop cancer cells from growing or cause them to self-destruct. Still others carry toxins to cancer cells.
Explore our
full portfolio
Our Videos
Scientific Update
Check our latest updates
ABSTRACT Purpose: To evaluate and confirm efficacy and safety of electrochemotherapy with bleomy- cin or cisplatin on cutaneous and subcutaneous tumour nodules of patients with malig- nant melanoma and other malignancies in a multicenter study.
Abstract. Background: Adjuvant intravesical instillations with bacillus Calmette-Gu ?erin (BCG) is the recommended treatment option for patients with intermediate- and high-risk non-muscle invasive bladder cancer (NMIBC). Despite adequate BCG treatment, a large proportion of patients experience a recurrence.